Retatrutide
10 mg vial · 30 mg GoQuick pen
Triple-agonist metabolic candidate. Our most requested research compound, released after research-intent confirmation.
- Appetite regulation
- Glucose control
- Body composition
99.4% (HPLC)
GoQuick pen
Research use only